findmyKOL
Clinical trialNCT00090610CompletedPhase 2Interventional

Second-Line Treatment for Patients With Platinum-Sensitive Ovarian Cancer

SponsorDuke UniversityEnrollment150Ovarian Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Florida Gynecologic Oncology

    Fort Myers, Florida, United States

  • Jupiter Medical Center-Gynecology Oncology and Gynecology

    Jupiter, Florida, United States

  • Florida Hospital/gyn/onc Department

    Orlando, Florida, United States

  • Hematology-Onc. Assoc. of the Quad Cities

    Bettendorf, Iowa, United States

  • University of Iowa

    Iowa City, Iowa, United States

  • Franklin Square Hospital Center/medstar Health-Section of Hematology/oncology

    Baltimore, Maryland, United States

  • Cancer Center at Hackensack

    Hackensack, New Jersey, United States

  • Columbia University College of Physicians and Surg

    New York, New York, United States

  • Hope: A Woman'S Cancer Center

    Asheville, North Carolina, United States

  • University of North Carolina/ Division of Gyn Oncology

    Chapel Hill, North Carolina, United States

  • Carolinas Medical Center/gyn Oncology Department

    Charlotte, North Carolina, United States

  • Duke University/division of Gynecologic Oncology

    Durham, North Carolina, United States

  • Forsyth Regional Cancer Center

    Winston-Salem, North Carolina, United States

  • Gynecologic Oncology and Surgery

    Oklahoma City, Oklahoma, United States

  • Pa Hematology/oncology Associates

    Philadelphia, Pennsylvania, United States

  • Western Pennsylvania Hospital

    Pittsburgh, Pennsylvania, United States

  • Musc-Div of Gyn/oncology

    Charleston, South Carolina, United States

  • the West Cancer Clinic

    Memphis, Tennessee, United States

  • Southwest Regional Cancer Center

    Austin, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2003
Primary completion
31 Mar 2009
Completion
31 Oct 2009
Last update posted
25 Feb 2015
Registered enrollment
150
Registry id
NCT00090610

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.